Spots Global Cancer Trial Database for moxifloxacin
Every month we try and update this database with for moxifloxacin cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| VEG111485: A QTc Study of Pazopanib | NCT00861029 | Carcinoma, Rena... | Pazopanib Placebo for paz... Moxifloxacin Placebo for mox... | 18 Years - | GlaxoSmithKline | |
| VEG111485: A QTc Study of Pazopanib | NCT00861029 | Carcinoma, Rena... | Pazopanib Placebo for paz... Moxifloxacin Placebo for mox... | 18 Years - | GlaxoSmithKline | |
| Moxifloxacin in Adjuvant Treatment of Patients With Operable Breast Cancer | NCT05114720 | Breast Cancer | standard adjuva... standard adjuva... | 18 Years - 70 Years | Sun Yat-sen University | |
| Study to Examine the Effect of HKI-272 on Rhythms of the Heart (Cardiac Repolarization) | NCT00708903 | Breast Cancer | neratinib Placebo Moxifloxacin | 18 Years - 50 Years | Puma Biotechnology, Inc. | |
| A Study to Investigate the Effect of Single Dose of AZD6094 (600 mg) on Cardiac Repolarization in Healthy Volunteers | NCT03258515 | Solid Tumors | AZD6094 200 mg Placebo Moxifloxacin | 18 Years - 55 Years | AstraZeneca | |
| Thorough QT/QTc (Corrected QT Interval) Study to Evaluate the Effect of Custirsen on Cardiac Repolarization | NCT01874561 | Cardiac Conduct... | Custirsen Placebo Moxifloxacin | 18 Years - 45 Years | Achieve Life Sciences | |
| Moxifloxacin in the Prevention of Bacteremia After High-dose Chemotherapy and Transplantation of Peripheral Stem Cells | NCT00398411 | Hodgkin Disease Non-Hodgkin Lym... Multiple Myelom... Bacteremia | moxifloxacin placebo | 18 Years - 75 Years | University of Cologne | |
| Moxifloxacin in Adjuvant Treatment of Patients With Operable Breast Cancer | NCT05114720 | Breast Cancer | standard adjuva... standard adjuva... | 18 Years - 70 Years | Sun Yat-sen University | |
| Study to Examine the Effect of HKI-272 on Rhythms of the Heart (Cardiac Repolarization) | NCT00708903 | Breast Cancer | neratinib Placebo Moxifloxacin | 18 Years - 50 Years | Puma Biotechnology, Inc. | |
| To Assess the Effects of Single Oral Dose of Selumetinib [AZD6244; ARRY-142886] [Hyd-Sulfate]), on QTc Interval in Healthy Male Volunteers | NCT02056392 | Solid Tumours | Selumetinib Moxifloxacin selumetinib pla... | 18 Years - 45 Years | AstraZeneca | |
| Moxifloxacin in the Prevention of Bacteremia After High-dose Chemotherapy and Transplantation of Peripheral Stem Cells | NCT00398411 | Hodgkin Disease Non-Hodgkin Lym... Multiple Myelom... Bacteremia | moxifloxacin placebo | 18 Years - 75 Years | University of Cologne | |
| To Assess the Effects of Single Oral Dose of Selumetinib [AZD6244; ARRY-142886] [Hyd-Sulfate]), on QTc Interval in Healthy Male Volunteers | NCT02056392 | Solid Tumours | Selumetinib Moxifloxacin selumetinib pla... | 18 Years - 45 Years | AstraZeneca | |
| Study of Ramucirumab (IMC-1121B) Therapy and Corrected QT (QTc) Interval Changes | NCT01017731 | Cancer Solid Tumor | IMC-1121B Moxifloxacin Diphenhydramine | 18 Years - | Eli Lilly and Company |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
